146 related articles for article (PubMed ID: 2409036)
1. Isoprinosine enhances the activation of sensitized lymphocytes by Epstein-Barr virus antigens.
Sundar SK; Barile G; Menezes J
Int J Immunopharmacol; 1985; 7(2):187-92. PubMed ID: 2409036
[TBL] [Abstract][Full Text] [Related]
2. Isoprinosine abolishes the blocking factor-mediated inhibition of lymphocyte responses to Epstein-Barr virus antigens and phytohemagglutinin.
Sundar SK; Menezes J
Int J Immunopharmacol; 1986; 8(1):101-6. PubMed ID: 2420730
[TBL] [Abstract][Full Text] [Related]
3. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice.
Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM
Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109
[TBL] [Abstract][Full Text] [Related]
4. Generation of Epstein-Barr virus antigen-specific suppressor T cells in vitro.
Sundar SK; Menezes J
Int J Cancer; 1985 Mar; 35(3):351-7. PubMed ID: 2579037
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells.
Harada S; Katsuki T; Yamamoto H; Hinuma Y
Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019
[TBL] [Abstract][Full Text] [Related]
6. Effect of isoprinosine on in vitro proliferative responses of human lymphocytes stimulated by antigen.
Ballet JJ; Morin A; Schmitt C; Agrapart M
Int J Immunopharmacol; 1982; 4(3):151-7. PubMed ID: 6179890
[TBL] [Abstract][Full Text] [Related]
7. Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions.
Portolés A; Ojeda G; Rojo JM; Portolés MP; Barasoain I
J Immunopharmacol; 1983; 5(3):245-56. PubMed ID: 6197489
[TBL] [Abstract][Full Text] [Related]
8. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)].
Morin A; Griscelli C; Daguillard F
Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345
[TBL] [Abstract][Full Text] [Related]
9. Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production.
Wiranowska-Stewart M; Hadden JW
Int J Immunopharmacol; 1986; 8(1):63-9. PubMed ID: 2420734
[TBL] [Abstract][Full Text] [Related]
10. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
[TBL] [Abstract][Full Text] [Related]
11. Effects of isoprinosine, levamisole, muramyl dipeptide, and SM1213 on lymphocyte and macrophage function in vitro.
Hadden JW
Cancer Treat Rep; 1978 Nov; 62(11):1981-5. PubMed ID: 83192
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
[TBL] [Abstract][Full Text] [Related]
13. The effect of isoprinosine on the PHA response of monocyte-depleted and undepleted peripheral blood mononuclear cells.
Jacobsen PL; Greenspan JS
J Immunopharmacol; 1982-1983; 4(4):355-65. PubMed ID: 6192176
[TBL] [Abstract][Full Text] [Related]
14. Isoprinosine enhances PHA responses and has potential effect on natural killer cell (NK) activity of uremic patients in vitro.
Silvennoinen-Kassinen S; Karttunen R; Tiilikainen A; Huttunen K
Nephron; 1987; 46(3):243-6. PubMed ID: 2442634
[TBL] [Abstract][Full Text] [Related]
15. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.
Misko IS; Sculley TB; Schmidt C; Moss DJ; Soszynski T; Burman K
Cell Immunol; 1991 Feb; 132(2):295-307. PubMed ID: 1846323
[TBL] [Abstract][Full Text] [Related]
16. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
Hank JA; Sondel PM
Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
18. Human cytotoxic T lymphocytes (CTL) against Epstein-Barr virus (EBV) infected cells: EBV specificity and involvement of major histocompatibility complex determinants in the lysis exerted by anti-EBV CTL toward HLA-compatible and allogeneic target cells.
Lakhdar M; Senik A; Fridman WH
Cell Immunol; 1984 Feb; 83(2):414-21. PubMed ID: 6198104
[TBL] [Abstract][Full Text] [Related]
19. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
20. Restoration of immune responses of aging hamsters by treatment with isoprinosine.
Tsang KY; Fudenberg HH; Gnagy MJ
J Clin Invest; 1983 Jun; 71(6):1750-5. PubMed ID: 6190840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]